IMMERSION (ALIMR.PA) Fundamental Analysis & Valuation

EPA:ALIMR • FR0013060100

2.36 EUR
-0.02 (-0.84%)
Last: Mar 4, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ALIMR.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, ALIMR scores 3 out of 10 in our fundamental rating. ALIMR was compared to 116 industry peers in the Software industry. ALIMR has a great financial health rating, but its profitability evaluates not so good. ALIMR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. ALIMR.PA Profitability Analysis

1.1 Basic Checks

  • ALIMR had positive earnings in the past year.
  • In multiple years ALIMR reported negative net income over the last 5 years.
  • In the past 5 years ALIMR always reported negative operating cash flow.
ALIMR.PA Yearly Net Income VS EBIT VS OCF VS FCFALIMR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2024 2025 0 500K -500K -1M -1.5M -2M

1.2 Ratios

  • With a Return On Assets value of 0.51%, ALIMR perfoms like the industry average, outperforming 43.10% of the companies in the same industry.
  • ALIMR's Return On Equity of 1.41% is in line compared to the rest of the industry. ALIMR outperforms 43.10% of its industry peers.
Industry RankSector Rank
ROA 0.51%
ROE 1.41%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALIMR.PA Yearly ROA, ROE, ROICALIMR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2024 2025 0 -50 -100

1.3 Margins

  • ALIMR has a Profit Margin (0.45%) which is in line with its industry peers.
  • ALIMR's Gross Margin of 21.06% is on the low side compared to the rest of the industry. ALIMR is outperformed by 83.62% of its industry peers.
  • In the last couple of years the Gross Margin of ALIMR has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 0.45%
GM 21.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.31%
GM growth 5Y0.02%
ALIMR.PA Yearly Profit, Operating, Gross MarginsALIMR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ALIMR.PA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, ALIMR has about the same amount of shares outstanding.
  • The number of shares outstanding for ALIMR remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for ALIMR has been reduced compared to a year ago.
ALIMR.PA Yearly Shares OutstandingALIMR.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2024 2025 200K 400K 600K 800K 1M
ALIMR.PA Yearly Total Debt VS Total AssetsALIMR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2024 2025 2M 4M 6M

2.2 Solvency

  • ALIMR has an Altman-Z score of 1.97. This is not the best score and indicates that ALIMR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ALIMR's Altman-Z score of 1.97 is in line compared to the rest of the industry. ALIMR outperforms 45.69% of its industry peers.
  • ALIMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACCN/A
WACCN/A
ALIMR.PA Yearly LT Debt VS Equity VS FCFALIMR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2024 2025 500K 1M 1.5M 2M

2.3 Liquidity

  • ALIMR has a Current Ratio of 1.86. This is a normal value and indicates that ALIMR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ALIMR (1.86) is better than 68.97% of its industry peers.
  • ALIMR has a Quick Ratio of 1.62. This is a normal value and indicates that ALIMR is financially healthy and should not expect problems in meeting its short term obligations.
  • ALIMR's Quick ratio of 1.62 is fine compared to the rest of the industry. ALIMR outperforms 60.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.62
ALIMR.PA Yearly Current Assets VS Current LiabilitesALIMR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ALIMR.PA Growth Analysis

3.1 Past

  • The earnings per share for ALIMR have decreased strongly by -40.00% in the last year.
  • The Revenue has grown by 21.10% in the past year. This is a very strong growth!
  • The Revenue has been growing slightly by 7.28% on average over the past years.
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.78%
Revenue 1Y (TTM)21.1%
Revenue growth 3Y11.05%
Revenue growth 5Y7.28%
Sales Q2Q%7.24%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALIMR.PA Yearly Revenue VS EstimatesALIMR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2M 4M 6M 8M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALIMR.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 78.67, the valuation of ALIMR can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALIMR is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.03. ALIMR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 78.67
Fwd PE N/A
ALIMR.PA Price Earnings VS Forward Price EarningsALIMR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALIMR.PA Per share dataALIMR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALIMR.PA Dividend Analysis

5.1 Amount

  • No dividends for ALIMR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALIMR.PA Fundamentals: All Metrics, Ratios and Statistics

IMMERSION

EPA:ALIMR (3/4/2026, 7:00:00 PM)

2.36

-0.02 (-0.84%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners76.58%
Ins Owner ChangeN/A
Market Cap3.00M
Revenue(TTM)6.60M
Net Income(TTM)30.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 78.67
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 1.41
P/tB 2.14
EV/EBITDA N/A
EPS(TTM)0.03
EY1.27%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.2
BVpS1.68
TBVpS1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.06
Profitability
Industry RankSector Rank
ROA 0.51%
ROE 1.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.45%
GM 21.06%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.31%
GM growth 5Y0.02%
F-ScoreN/A
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.62
Altman-Z 1.97
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.1%
Revenue growth 3Y11.05%
Revenue growth 5Y7.28%
Sales Q2Q%7.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

IMMERSION / ALIMR.PA FAQ

Can you provide the ChartMill fundamental rating for IMMERSION?

ChartMill assigns a fundamental rating of 3 / 10 to ALIMR.PA.


Can you provide the valuation status for IMMERSION?

ChartMill assigns a valuation rating of 0 / 10 to IMMERSION (ALIMR.PA). This can be considered as Overvalued.


Can you provide the profitability details for IMMERSION?

IMMERSION (ALIMR.PA) has a profitability rating of 2 / 10.


What are the PE and PB ratios of IMMERSION (ALIMR.PA) stock?

The Price/Earnings (PE) ratio for IMMERSION (ALIMR.PA) is 78.67 and the Price/Book (PB) ratio is 1.41.


How financially healthy is IMMERSION?

The financial health rating of IMMERSION (ALIMR.PA) is 7 / 10.